05.11.2019 • TopicsCloudDassault SystemesWebinar

Expert-Webinar: How to Elevate your Lab to the Cloud

©totojang1977/Shutterstock
©totojang1977/Shutterstock

Life sciences organizations need to optimize operations by improving efficiency and adhere to regulations while driving innovations. These challenges also apply to the lab environment, which needs to remove both inefficiencies and compliance risks and provide a collaborative environment for innovation.

If you’re keen to discover how a digital lab can enable end-to-end digital workflows and leverage digital continuity throughout the entire product life-cycle management, then you need to join this webinar, presented by Wiley and Dassault Systèmes:

 

Register to attend the on-demand version of the webinar.

 

Some of your key learnings will be:

  • Key Industry Drivers pushing labs toward end-to-end digital workflows
  • How the cloud enables and accelerates transformation in Life Sciences
  • How mobile procedure and method execution supports the full lab workflow

 

Please visit this website to receive further insights.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.